Beijing SL Pharmaceutical Co Ltd (002038) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Beijing SL Pharmaceutical Co Ltd (002038) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥66.55 Million ≈ $9.74 Million USD) by net assets (CN¥5.70 Billion ≈ $834.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Beijing SL Pharmaceutical Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Beijing SL Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Beijing SL Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing SL Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing SL Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Arrowhead Properties Ltd B JSE:FTB	0.046x
Anhui Huaheng Biotechnology Co. Ltd. A SHG:688639	-0.004x
INKON Life Technology Co Ltd SHE:300143	0.027x
Quanex Building Products NYSE:NX	0.026x
Risesun Real Estate Development Co Ltd SHE:002146	-0.025x
Jdd Tech New Mat Co Ltd SHE:301538	0.036x
Replimune Group Inc NASDAQ:REPL	-0.313x
Lancy Co Ltd SHE:002612	0.018x

Annual Cash Flow Conversion Efficiency for Beijing SL Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Beijing SL Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see 002038 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.19 Billion ≈ $759.25 Million	CN¥257.66 Million ≈ $37.70 Million	0.050x	+22.90%
2024-12-31	CN¥5.58 Billion ≈ $816.62 Million	CN¥225.49 Million ≈ $33.00 Million	0.040x	-48.99%
2023-12-31	CN¥5.81 Billion ≈ $850.19 Million	CN¥460.20 Million ≈ $67.34 Million	0.079x	+11.33%
2022-12-31	CN¥5.48 Billion ≈ $801.78 Million	CN¥389.82 Million ≈ $57.04 Million	0.071x	-18.44%
2021-12-31	CN¥5.33 Billion ≈ $779.39 Million	CN¥464.63 Million ≈ $67.99 Million	0.087x	+4.57%
2020-12-31	CN¥4.98 Billion ≈ $729.42 Million	CN¥415.84 Million ≈ $60.85 Million	0.083x	-39.59%
2019-12-31	CN¥4.82 Billion ≈ $705.49 Million	CN¥665.83 Million ≈ $97.43 Million	0.138x	+28.62%
2018-12-31	CN¥4.52 Billion ≈ $661.20 Million	CN¥485.17 Million ≈ $71.00 Million	0.107x	+21.25%
2017-12-31	CN¥4.30 Billion ≈ $629.14 Million	CN¥380.72 Million ≈ $55.71 Million	0.089x	-12.31%
2016-12-31	CN¥3.93 Billion ≈ $575.09 Million	CN¥396.86 Million ≈ $58.07 Million	0.101x	-27.73%
2015-12-31	CN¥3.61 Billion ≈ $528.73 Million	CN¥504.87 Million ≈ $73.88 Million	0.140x	-4.41%
2014-12-31	CN¥3.18 Billion ≈ $465.50 Million	CN¥465.00 Million ≈ $68.04 Million	0.146x	+8.93%
2013-12-31	CN¥2.59 Billion ≈ $378.85 Million	CN¥347.41 Million ≈ $50.84 Million	0.134x	-28.91%
2012-12-31	CN¥2.11 Billion ≈ $308.98 Million	CN¥398.60 Million ≈ $58.33 Million	0.189x	+39.20%
2011-12-31	CN¥1.69 Billion ≈ $246.66 Million	CN¥228.59 Million ≈ $33.45 Million	0.136x	-31.02%
2010-12-31	CN¥1.21 Billion ≈ $177.26 Million	CN¥238.13 Million ≈ $34.85 Million	0.197x	+10.81%
2009-12-31	CN¥983.06 Million ≈ $143.85 Million	CN¥174.41 Million ≈ $25.52 Million	0.177x	-30.38%
2008-12-31	CN¥762.61 Million ≈ $111.59 Million	CN¥194.32 Million ≈ $28.44 Million	0.255x	+59.16%
2007-12-31	CN¥551.93 Million ≈ $80.76 Million	CN¥88.36 Million ≈ $12.93 Million	0.160x	+18.56%
2006-12-31	CN¥426.20 Million ≈ $62.37 Million	CN¥57.55 Million ≈ $8.42 Million	0.135x	+8.78%
2005-12-31	CN¥382.49 Million ≈ $55.97 Million	CN¥47.48 Million ≈ $6.95 Million	0.124x	+43.52%
2004-12-31	CN¥361.45 Million ≈ $52.89 Million	CN¥31.26 Million ≈ $4.57 Million	0.086x	-67.43%
2003-12-31	CN¥115.05 Million ≈ $16.84 Million	CN¥30.55 Million ≈ $4.47 Million	0.266x	--

About Beijing SL Pharmaceutical Co Ltd

SHE:002038 China Drug Manufacturers - Specialty & Generic

Market Cap

$763.69 Million

CN¥5.22 Billion CNY

Market Cap Rank

#10276 Global

#2787 in China

Share Price

CN¥5.08

Change (1 day)

+0.99%

52-Week Range

CN¥5.03 - CN¥8.98

All Time High

CN¥10151.79